4976 - 5000 of 5662 Results
Title
Year
- Next-generation active immunization approach for synucleinopathies: implications for Parkinson’s disease clinical trials2014OPENTitle: Next-generation active immunization approach for synucleinopathies: implications for Parkinson’s disease clinical trialsJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 127Issue #: 6Start Page: 861End Page: 879Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-014-1256-4Best OA location URL: https://europepmc.org/articles/pmc4034750?pdf=renderCitation Count: 211
- Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease2014OPENTitle: Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 111Issue #: 7Start Page: 2626End Page: 2631Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1318306111Best OA location URL: https://www.pnas.org/content/pnas/111/7/2626.full.pdfCitation Count: 344
-
OPENTitle: Heterogeneity in primary dystonia: Lessons from THAP1, GNAL, and TOR1A in Amish‐MennonitesJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 6Start Page: 812End Page: 818Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25818Best OA location URL: https://europepmc.org/articles/pmc4013240?pdf=renderCitation Count: 36
- Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury2014OPENTitle: Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injuryJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 10Issue #: 1SStart Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2013.12.011Best OA location URL: https://europepmc.org/articles/pmc4201593?pdf=renderCitation Count: 66
-
OPENTitle: Inosine to Increase Serum and Cerebrospinal Fluid Urate in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 71Issue #: 2Start Page: 141End Page: 141Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2013.5528Best OA location URL: https://europepmc.org/articles/pmc3940333?pdf=renderCitation Count: 215
-
OPENTitle: Clinicopathological Outcomes of Prospectively Followed Normal Elderly Brain Bank VolunteersJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 73Issue #: 3Start Page: 244End Page: 252Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/nen.0000000000000046Best OA location URL: https://academic.oup.com/jnen/article-pdf/73/3/244/17419487/73-3-244.pdfCitation Count: 76
-
OPENTitle: Transgenic mice expressing S129 phosphorylation mutations in α-synucleinJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 563Issue #:Start Page: 96End Page: 100Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2014.01.033Best OA location URL: https://europepmc.org/articles/pmc4059511?pdf=renderCitation Count: 13
- Clinical Comparison of 99mTc Exametazime and 123I Ioflupane SPECT in Patients with Chronic Mild Traumatic Brain Injury2014OPENTitle: Clinical Comparison of 99mTc Exametazime and 123I Ioflupane SPECT in Patients with Chronic Mild Traumatic Brain InjuryJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 9Issue #: 1Start Page: e87009End Page: e87009Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0087009Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0087009&type=printableCitation Count: 16
-
OPENTitle: Treatment of Psychosis and Dementia in Parkinson’s DiseaseJournal Name: Current Treatment Options in NeurologyPublisher: Springer Science and Business Media LLCVol: 16Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11940-013-0281-2Best OA location URL: https://europepmc.org/articles/pmc3994190?pdf=renderCitation Count: 111
- Attentional resource allocation and swallowing safety in Parkinson's disease: A dual task study2014OPENTitle: Attentional resource allocation and swallowing safety in Parkinson's disease: A dual task studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #: 4Start Page: 439End Page: 443Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2013.12.011Best OA location URL: https://europepmc.org/articles/pmc4646094?pdf=renderCitation Count: 42
- Quantitative neuropathology associated with chronic manganese exposure in South African mine workers2014OPENTitle: Quantitative neuropathology associated with chronic manganese exposure in South African mine workersJournal Name: NeuroToxicologyPublisher: Elsevier BVVol: 45Issue #:Start Page: 260End Page: 266Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuro.2013.12.008Best OA location URL: https://europepmc.org/articles/pmc4072755?pdf=renderCitation Count: 42
- ALS-FTD Complex Disorder due to <b><i>C9ORF72</i></b> Gene Mutation: Description of First Polish Family2014OPENTitle: ALS-FTD Complex Disorder due to <b><i>C9ORF72</i></b> Gene Mutation: Description of First Polish FamilyJournal Name: European NeurologyPublisher: S. Karger AGVol: 72Issue #: 1-2Start Page: 64End Page: 71Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1159/000362267Best OA location URL: https://karger.com/ene/article-pdf/72/1-2/64/2724525/000362267.pdfCitation Count: 1
-
OPENTitle: Continuous in-home monitoring of essential tremorJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #: 1Start Page: 37End Page: 40Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2013.09.009Best OA location URL: https://europepmc.org/articles/pmc3946846?pdf=renderCitation Count: 62
-
OPENTitle: Detraining outcomes with expiratory muscle strength training in Parkinson diseaseJournal Name: Journal of Rehabilitation Research and DevelopmentPublisher: Journal of Rehabilitation Research & DevelopmentVol: 51Issue #: 2Start Page: 305End Page: 310Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1682/jrrd.2013.05.0101Best OA location URL: https://europepmc.org/articles/pmc4644088?pdf=renderCitation Count: 49
- Estrogen Receptor α Variants Affect Age at Onset of Alzheimer's Disease in a Multiethnic Female Cohort2014OPENTitle: Estrogen Receptor α Variants Affect Age at Onset of Alzheimer's Disease in a Multiethnic Female CohortJournal Name: Dementia and Geriatric Cognitive DisordersPublisher: S. Karger AGVol: 38Issue #: 3-4Start Page: 200End Page: 213Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1159/000355559Best OA location URL: https://karger.com/dem/article-pdf/38/3-4/200/2570057/000355559.pdfCitation Count: 23
- Osteopontin Expression in the Brain Triggers Localized Inflammation and Cell Death When Immune Cells Are Activated by Pertussis Toxin2014OPENTitle: Osteopontin Expression in the Brain Triggers Localized Inflammation and Cell Death When Immune Cells Are Activated by Pertussis ToxinJournal Name: Mediators of InflammationPublisher: Hindawi LimitedVol: 2014Issue #:Start Page: 1End Page: 12Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2014/358218Best OA location URL: https://downloads.hindawi.com/journals/mi/2014/358218.pdfCitation Count: 9
- Peripheral Administration of the Selective Inhibitor of Soluble Tumor Necrosis Factor (TNF) XPro®1595 Attenuates Nigral Cell Loss and Glial Activation in 6-OHDA Hemiparkinsonian Rats2014OPENTitle: Peripheral Administration of the Selective Inhibitor of Soluble Tumor Necrosis Factor (TNF) XPro®1595 Attenuates Nigral Cell Loss and Glial Activation in 6-OHDA Hemiparkinsonian RatsJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 4Issue #: 3Start Page: 349End Page: 360Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-140410Best OA location URL: https://europepmc.org/articles/pmc4154985?pdf=renderCitation Count: 90
-
OPENTitle: Select E2 enzymes differentially regulate parkin activation and mitophagyJournal Name: Journal of Cell SciencePublisher: The Company of BiologistsVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1242/jcs.147520Best OA location URL: https://jcs.biologists.org/content/joces/127/16/3488.full.pdfCitation Count: 68
- Temporal Characteristics of High-Frequency Lower-Limb Oscillation during Freezing of Gait in Parkinson’s Disease2014OPENTitle: Temporal Characteristics of High-Frequency Lower-Limb Oscillation during Freezing of Gait in Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: Hindawi LimitedVol: 2014Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2014/606427Best OA location URL: https://downloads.hindawi.com/journals/pd/2014/606427.pdfCitation Count: 25
- Effects of Baseline CSF α-Synuclein on Regional Brain Atrophy Rates in Healthy Elders, Mild Cognitive Impairment and Alzheimer’s Disease2013OPENTitle: Effects of Baseline CSF α-Synuclein on Regional Brain Atrophy Rates in Healthy Elders, Mild Cognitive Impairment and Alzheimer’s DiseaseJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 12Start Page: e85443End Page: e85443Publication Date:Open Access(OA) Status: OPENLicense: cc0DOI - Digital Object Identifier: 10.1371/journal.pone.0085443Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0085443&type=printableCitation Count: 17
- Human A53T α-Synuclein Causes Reversible Deficits in Mitochondrial Function and Dynamics in Primary Mouse Cortical Neurons2013OPENTitle: Human A53T α-Synuclein Causes Reversible Deficits in Mitochondrial Function and Dynamics in Primary Mouse Cortical NeuronsJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 12Start Page: e85815End Page: e85815Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0085815Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0085815&type=printableCitation Count: 55
- Pedunculopontine Nucleus Area Oscillations during Stance, Stepping and Freezing in Parkinson’s Disease2013OPENTitle: Pedunculopontine Nucleus Area Oscillations during Stance, Stepping and Freezing in Parkinson’s DiseaseJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 12Start Page: e83919End Page: e83919Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0083919Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0083919&type=printableCitation Count: 74
-
OPENTitle: A noninvasive handheld assistive device to accommodate essential tremor: A pilot studyJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 6Start Page: 838End Page: 842Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25796Best OA location URL: https://europepmc.org/articles/pmc4156033?pdf=renderCitation Count: 49
- Expression of peroxisome proliferator-activated receptor-gamma in the substantia nigra of hemiparkinsonian nonhuman primates2013OPENTitle: Expression of peroxisome proliferator-activated receptor-gamma in the substantia nigra of hemiparkinsonian nonhuman primatesJournal Name: Neurological ResearchPublisher: Informa UK LimitedVol: 36Issue #: 7Start Page: 634End Page: 646Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1179/1743132813y.0000000305Best OA location URL: https://europepmc.org/articles/pmc4254814?pdf=renderCitation Count: 27
-
OPENTitle: Results of the citalopram to enhance cognition in Huntington disease trialJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 3Start Page: 401End Page: 405Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25750Best OA location URL: https://europepmc.org/articles/pmc3960314?pdf=renderCitation Count: 54